LIDOCAINE-BAXTER lidocaine (lignocaine) hydrochloride (as monohydrate) 400 mg/20 mL solution for injection vial Australia - englanti - Department of Health (Therapeutic Goods Administration)

lidocaine-baxter lidocaine (lignocaine) hydrochloride (as monohydrate) 400 mg/20 ml solution for injection vial

baxter healthcare pty ltd - lidocaine hydrochloride monohydrate, quantity: 426.6 mg (equivalent: lidocaine hydrochloride, qty 400 mg) - injection, solution - excipient ingredients: sodium chloride; hydrochloric acid; water for injections; sodium hydroxide - for production of local or regional anaesthesia by nerve block, infiltration injection, caudal or other epidural blocks. treatment or prophylaxis of life-threatening ventricular arrhythmias, including those associated with myocardial infarction, general anaesthesia in patients predisposed to ventricular arrhythmias, digitalis intoxication, or following resuscitation from cardiac arrest.

LIDOCAINE-BAXTER lidocaine (lignocaine) hydrochloride (as monohydrate) 100 mg/5 mL solution for injection ampoule Australia - englanti - Department of Health (Therapeutic Goods Administration)

lidocaine-baxter lidocaine (lignocaine) hydrochloride (as monohydrate) 100 mg/5 ml solution for injection ampoule

baxter healthcare pty ltd - lidocaine hydrochloride monohydrate, quantity: 106.65 mg (equivalent: lidocaine hydrochloride, qty 100 mg) - injection, solution - excipient ingredients: sodium chloride; sodium hydroxide; hydrochloric acid; water for injections - for production of local or regional anaesthesia by nerve block, infiltration injection, caudal or other epidural blocks. treatment or prophylaxis of life-threatening ventricular arrhythmias, including those associated with myocardial infarction, general anaesthesia in patients predisposed to ventricular arrhythmias, digitalis intoxication, or following resuscitation from cardiac arrest.

Brevibloc Premixed 10 mg/ml Solution for Injection Irlanti - englanti - HPRA (Health Products Regulatory Authority)

brevibloc premixed 10 mg/ml solution for injection

baxter healthcare limited - esmolol hydrochloride - solution for injection - 10 milligram(s)/millilitre - beta blocking agents, selective; esmolol

FEIBA 50 Units/ml Pdr+Solv for soln for Inf Irlanti - englanti - HPRA (Health Products Regulatory Authority)

feiba 50 units/ml pdr+solv for soln for inf

baxter healthcare limited - feiba - pdr+solv for soln for inf - 50 units/ml

FEIBA 25 Units/ml Pdr+Solv for soln for Inf Irlanti - englanti - HPRA (Health Products Regulatory Authority)

feiba 25 units/ml pdr+solv for soln for inf

baxter healthcare limited - feiba - pdr+solv for soln for inf - 25 units/ml

Sodium Chloride 0.45 % w/v and Glucose 2.5% w/v Solution for Infusion BP Irlanti - englanti - HPRA (Health Products Regulatory Authority)

sodium chloride 0.45 % w/v and glucose 2.5% w/v solution for infusion bp

baxter healthcare limited - sodium chloride; sodium chloride; glucose monohydrate; glucose monohydrate - solution for infusion - 0.45 2.5 percent weight/volume - salt solutions; sodium chloride

Extraneal (Icodextrin 7.5%) Solution for peritoneal dialysis Malta - englanti - Medicines Authority

extraneal (icodextrin 7.5%) solution for peritoneal dialysis

baxter healthcare limited - calcium chloride; icodextrin; magnesium chloride anhydrous; sodium chloride; sodium lactate - solution for peritoneal dialysis - calcium chloride 96 mmol/l; icodextrin 7.5 % (w/v); magnesium chloride anhydrous 40 mmol/l; sodium chloride 1.75 mmol/l; sodium lactate 0.25 mmol/l - blood substitutes and perfusion solutions

Plasma-Lyte® 148 (pH 7.4) solution for infusion Irlanti - englanti - HPRA (Health Products Regulatory Authority)

plasma-lyte® 148 (ph 7.4) solution for infusion

baxter healthcare limited - sodium chloride; magnesium chloride hexahydrate; potassium chloride; sodium gluconate; sodium acetate trihydrate - solution for infusion - unknown - solutions affecting the electrolyte balance; electrolytes

Dianeal PD4 Glucose 1.36 % w/v (13.6 mg/ml), Solution for peritoneal dialysis Irlanti - englanti - HPRA (Health Products Regulatory Authority)

dianeal pd4 glucose 1.36 % w/v (13.6 mg/ml), solution for peritoneal dialysis

baxter healthcare limited - glucose, anhydrous; sodium chloride; sodium lactate; calcium chloride; magnesium chloride - solution for dialysis - 13.6 milligram(s)/millilitre - hypertonic solutions

Dianeal PD4 Glucose 2.27 % w/v (22.7 mg/ml), Solution for peritoneal dialysis Irlanti - englanti - HPRA (Health Products Regulatory Authority)

dianeal pd4 glucose 2.27 % w/v (22.7 mg/ml), solution for peritoneal dialysis

baxter healthcare limited - glucose, anhydrous; calcium chloride dihydrate; magnesium chloride hexahydrate; sodium lactate; sodium chloride - solution for dialysis - 2.27 percent weight/volume - hypertonic solutions